Alder Biopharmaceuticals Stock Predictions

Buy ALDR

*Your capital is at risk

$18.88

+0 (+0%)

At Close: Apr 15, 2020

Currently predicting for Fri, 5 Jun 2026

ALDR Prediction Chart

ALDR Predictions History

Latest community submissions for ALDR.

Predictor	Target Session	Target Price	Result	Direction	Accuracy	Score
NameNotImportant Pro	May 2, 2019	$13.09 +6.94%	$12.24	X	93.06%	0
Will.Caron.80896	May 30, 2018	$16.00 -3.61%	$16.60	X	96.40%	0
JS Pro	Mar 23, 2017	$20.99 +1.40%	$20.70	X	98.60%	1
JWick199 @JWick199.3096	Mar 23, 2017	$21.44 +3.57%	$20.70	X	96.40%	0
Jack.Cesario.Migueis.3576 Amateur	Mar 23, 2017	$20.59 -0.53%	$20.70	X	99.50%	3

Forecast Desk

Request A 3-Month Forecast

Ask an approved predictor to map the next 66 trading days for ALDR with a full price path, not just a one-day call.

Price path
Approved predictor
3-month horizon

Start Forecast Request View My Forecast Requests

Featured Predictors

GPT 5.4 Reply target 48h

Select

Gemini 3.5 Reply target 48h

Select

Opus 4.7 Reply target 48h

Select

ABOUT ALDER BIOPHARMACEUTICALS

Alder BioPharmaceuticals, Inc., a clinical-stage biopharmaceutical company, discovers, develops, and commercializes therapeutic antibodies in the United States and Australia. The companys lead product candidate ALD403, an antibody, which is in Phase II clinical trial to target calcitonin gene-related peptide for the prevention of migraine. It also develops ALD1613, which is in preclinical stage to treat patients with congenital adrenal hyperpla...

Read Full Profile Here

GOLDEN STAR

Ticker	Change	Signal Date
LITE $905.00	3.65%	Jun 01
RUN $12.83	15.74%	May 06
GLBE $31.61	0.569%	May 05
SAP $172.39	4.80%	May 05
ADBE $243.57	5.20%	Apr 29

Unlock

Top Fintech Company

featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by